CROCETTI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.879
EU - Europa 4.101
AS - Asia 2.807
SA - Sud America 309
AF - Africa 61
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.826
PL - Polonia 1.640
RU - Federazione Russa 1.001
CN - Cina 701
SG - Singapore 698
IT - Italia 647
HK - Hong Kong 586
VN - Vietnam 283
BR - Brasile 247
KR - Corea 221
IE - Irlanda 198
SE - Svezia 188
FI - Finlandia 89
FR - Francia 86
DE - Germania 78
GB - Regno Unito 78
IN - India 73
BD - Bangladesh 64
ID - Indonesia 52
AU - Australia 34
CA - Canada 30
AR - Argentina 24
JP - Giappone 24
JO - Giordania 23
BE - Belgio 22
NL - Olanda 21
ES - Italia 17
MX - Messico 15
CI - Costa d'Avorio 13
TR - Turchia 12
ZA - Sudafrica 12
IQ - Iraq 11
UA - Ucraina 11
EC - Ecuador 10
PK - Pakistan 9
NG - Nigeria 8
EG - Egitto 7
CL - Cile 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
KZ - Kazakistan 5
PY - Paraguay 5
TW - Taiwan 5
CH - Svizzera 4
CO - Colombia 4
DZ - Algeria 4
IR - Iran 4
KE - Kenya 4
LV - Lettonia 4
MA - Marocco 4
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
SV - El Salvador 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BJ - Benin 2
BY - Bielorussia 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 12.193
Salva come PNG Salva come JPEG
Città #
Warsaw 1.636
Santa Clara 1.148
Ashburn 607
Hong Kong 533
Singapore 509
Fairfield 323
San Jose 286
Seoul 218
Dublin 196
Hefei 194
Chandler 193
Seattle 164
Woodbridge 138
Florence 133
Council Bluffs 132
Beijing 131
Cambridge 120
Ann Arbor 116
Houston 113
Wilmington 107
Buffalo 89
Milan 86
Ho Chi Minh City 81
Altamura 78
Lawrence 77
Dallas 72
Los Angeles 66
Hanoi 63
Lauterbourg 55
Rome 55
Moscow 52
Princeton 52
Jakarta 43
The Dalles 42
Helsinki 36
Mumbai 36
Munich 32
Melbourne 31
New York 31
Shanghai 30
Kent 29
Boston 28
Medford 25
Paris 25
Boardman 24
Tokyo 23
Dong Ket 22
Brussels 21
San Diego 19
Lappeenranta 18
London 18
São Paulo 17
Clifton 15
Frankfurt am Main 15
Orem 15
Abidjan 13
Bologna 13
Turku 13
Chicago 12
Jacksonville 12
Naples 12
Barcelona 11
Haiphong 11
Phoenix 11
Redondo Beach 11
Austin 10
Da Nang 10
Guangzhou 10
Palermo 10
West Jordan 10
Brooklyn 9
Toronto 9
Yubileyny 9
Amsterdam 8
Chennai 8
Hillsboro 8
Johannesburg 8
Miano 8
Tianjin 8
Turin 8
Abuja 7
Baghdad 7
Bengaluru 7
Norwalk 7
Shenzhen 7
Belo Horizonte 6
Falls Church 6
Gavirate 6
Genoa 6
Hải Dương 6
Izmir 6
Manchester 6
Padua 6
Rio de Janeiro 6
Salt Lake City 6
Vancouver 6
Bắc Ninh 5
Cairo 5
Curitiba 5
Durham 5
Totale 8.791
Salva come PNG Salva come JPEG
Nome #
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 348
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 344
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 323
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 323
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 308
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 299
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 299
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 296
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 294
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 280
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 278
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 274
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 263
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 260
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 255
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 244
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 240
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 223
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 222
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 219
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 213
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 212
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 207
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 202
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 201
Cinnoline derivatives as human neutrophil elastase inhibitors 195
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 191
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers 184
A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases. 183
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 183
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 172
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 166
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 166
Editorial: Serine protease inhibitors and their therapeutic applications 165
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 165
Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines 159
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 159
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 153
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 152
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications 150
New Panx-1 Blockers: Synthesis, Biological Evaluation and Molecular Dynamic Studies 144
GABAA receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present) 139
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity 138
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 135
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 134
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 132
3,8-Disubstituted Pyrazolo[1,5-a]quinazoline as GABAA Receptor Modulators: Synthesis, Electrophysiological Assays, and Molecular Modelling Studies 131
Design and synthesis of the first indole-based blockers of Panx-1 channel 130
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 129
New insights on the arylpiperazinylalkyl pyridazinone ET1 as potent antinociceptive and anti-inflammatory agent 124
X-ray structural study of human neutrophil elastase inhibition with a series of azaindoles, azaindazoles and isoxazolones 122
Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments 121
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 120
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 119
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 119
Synthesis of 3-Carboxy-6-sulfamoylquinolones and Mefloquine-Based Compounds as Panx1 Blockers: Molecular Docking, Electrophysiological and Cell Culture Studies 115
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening 112
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 111
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes 108
New heterocyclic A1/A3 adenosine receptor ligands through molecular simplification strategies 104
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 104
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 94
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 92
Synthesis and Anti‐Hyperalgesic Efficacy of MP‐103, a Non‐Racemic Enantiomeric Mixture of a New 1,4‐Diazabicyclo[4.3.0]nonan‐9‐one 91
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors 88
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors 62
Labeling Peptides with Radioiodine: An Overview of Traditional and Emerging Techniques 59
New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli 47
Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 Mpro from 2022 to 2024 39
Insights into the complexity of SARS-CoV-2 Mpro inhibition: Ebselen and its derivatives impair dimerisation of the enzyme 36
Abnormal purinergic signaling contributes to development of renal cysts in autosomal dominant polycystic kidney disease 23
Discovery of Potent PDE4 Inhibitors with 3(2H)-Pyridazinone Scaffold: Synthesis, In Silico Studies and In Vitro/Vivo Evaluation 11
Totale 12.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/2022411 14 14 35 12 18 29 12 35 20 33 100 89
2022/2023986 96 233 47 71 54 170 126 56 85 5 31 12
2023/2024389 11 41 64 12 22 40 15 106 11 36 22 9
2024/20253.315 110 287 161 422 932 444 80 146 385 73 120 155
2025/20264.195 388 552 441 321 398 144 529 183 308 299 186 446
Totale 12.403